Cara Therapeutics, Inc. (NASDAQ:CARA) shareholders are no doubt pleased to see that the share price has bounced 34% in the last month, although it is still struggling to make up recently lost ground. ...
Source LinkCara Therapeutics, Inc. (NASDAQ:CARA) shareholders are no doubt pleased to see that the share price has bounced 34% in the last month, although it is still struggling to make up recently lost ground. ...
Source Link
Comments